Trade Summary

4 days ago, McCourt Thomas A, serving as CEO at Ironwood Pharmaceuticals Inc (IRWD), sold 198,283 shares at $3.73 per share, for a total transaction value of $739,929.00. Following this transaction, McCourt Thomas A now holds 1,489,002 shares of IRWD.

This sale represents a 12.00% decrease in McCourt Thomas A's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, February 23, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, February 25, 2026, 2 days after the trade was made.

Ironwood Pharmaceuticals Inc operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.